Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study

被引:0
作者
Mara Persano
Margherita Rimini
Toshifumi Tada
Goki Suda
Shigeo Shimose
Masatoshi Kudo
Jaekyung Cheon
Fabian Finkelmeier
Ho Yeong Lim
Lorenza Rimassa
José Presa
Gianluca Masi
Changhoon Yoo
Sara Lonardi
Francesco Tovoli
Takashi Kumada
Naoya Sakamoto
Hideki Iwamoto
Tomoko Aoki
Hong Jae Chon
Vera Himmelsbach
Tiziana Pressiani
Takumi Kawaguchi
Margarida Montes
Caterina Vivaldi
Caterina Soldà
Fabio Piscaglia
Atsushi Hiraoka
Takuya Sho
Takashi Niizeki
Naoshi Nishida
Christoph Steup
Massimo Iavarone
Giovanni Di Costanzo
Fabio Marra
Mario Scartozzi
Emiliano Tamburini
Giuseppe Cabibbo
Francesco Giuseppe Foschi
Marianna Silletta
Masashi Hirooka
Kazuya Kariyama
Joji Tani
Masanori Atsukawa
Koichi Takaguchi
Ei Itobayashi
Shinya Fukunishi
Kunihiko Tsuji
Toru Ishikawa
Kazuto Tajiri
机构
[1] University Hospital of Cagliari,Medical Oncology
[2] IRCCS San Raffaele Hospital,Department of Medical Oncology
[3] Japanese Red Cross Himeji Hospital,Department of Internal Medicine
[4] Hokkaido University,Department of Gastroenterology and Hepatology, Graduate School of Medicine
[5] Kurume University School of Medicine,Division of Gastroenterology, Department of Medicine
[6] Kindai University Faculty of Medicine,Department of Gastroenterology and Hepatology
[7] CHA University School of Medicine,Department of Medical Oncology, CHA Bundang Medical Center
[8] University Hospital Frankfurt,Department of Internal Medicine 1
[9] Goethe University,Department of Medicine, Samsung Medical Center, School of Medicine
[10] Sungkyunkwan University,Department of Biomedical Sciences
[11] Humanitas University,Unit of Medical Oncology 2
[12] Humanitas Cancer Center,Department of Translational Research and New Technologies in Medicine and Surgery
[13] IRCCS Humanitas Research Hospital,Department of Oncology, ASAN Medical Center
[14] Liver Unit-CHTMAD,Oncology Unit 1
[15] University Hospital of Pisa,Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases
[16] University of Pisa,Department of Nursing
[17] University of Ulsan College of Medicine,Gastroenterology Center
[18] Veneto Institute of Oncology IOV-IRCCS,Division of Gastroenterology and Hepatology
[19] IRCCS Azienda Ospedaliero-Universitaria di Bologna,Dipartimento di Medicina Sperimentale e Clinica
[20] Gifu Kyoritsu University,Department of Oncology and Palliative Care, Cardinale G Panico
[21] Ehime Prefectural Central Hospital,Section of Gastroenterology and Hepatology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, PROMISE
[22] Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano,Department of Internal Medicine
[23] Department of Hepatology,Division of Medical Oncology
[24] Università di Firenze,Department of Gastroenterology and Metabology
[25] Tricase City Hospital,Department of Gastroenterology
[26] University of Palermo,Department of Gastroenterology and Hepatology
[27] Ospedale per gli Infermi di Faenza,Division of Gastroenterology and Hepatology, Department of Internal Medicine
[28] Policlinico Universitario Campus Bio-Medico,Department of Hepatology
[29] Ehime University Graduate School of Medicine,Department of Gastroenterology
[30] Okayama City Hospital,Department of Gastroenterology
[31] Kagawa University,Center of Gastroenterology
[32] Nippon Medical School,Department of Gastroenterology
[33] Kagawa Prefectural Central Hospital,Department of Gastroenterology
[34] Asahi General Hospital,Hepato
[35] Osaka Medical and Pharmaceutical University,biliary Center
[36] Teine Keijinkai Hospital,Department of Gastroenterology and Hepatology
[37] Saiseikai Niigata Hospital,Department of Gastroenterology
[38] Toyama University Hospital,Division of Gastroenterology and Hepatology, Department of Internal medicine
[39] Japanese Red Cross Matsuyama Hospital,Department of Gastroenterology
[40] Ogaki Municipal Hospital,Department of Clinical Research
[41] Japanese Red Cross Takamatsu Hospital,Division of Gastroenterology and Hepatology
[42] Hyogo Medical University,Department of Hepatology
[43] Gunma Saiseikai Maebashi Hospital,Department of Surgery
[44] National Hospital Organization Takasaki General Medical Center,Department of Gastroenterology
[45] Otakanomori Hospital,Drug Development Unit
[46] Hamamatsu University School of Medicine,Department of Oncology
[47] Kansai Medical University,undefined
[48] National Hospital Organization Takasaki General Medical Center,undefined
[49] Sarah Cannon Research Institute UK,undefined
[50] IRCCS San Raffaele Scientific Institute Hospital,undefined
来源
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词
Advanced HCC; Atezolizumab plus bevacizumab; First-line therapy; Lenvatinib;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:5591 / 5602
页数:11
相关论文
共 210 条
  • [41] Kakizaki S(undefined)undefined undefined undefined undefined-undefined
  • [42] Nagashima T(undefined)undefined undefined undefined undefined-undefined
  • [43] Namikawa M(undefined)undefined undefined undefined undefined-undefined
  • [44] Tojima H(undefined)undefined undefined undefined undefined-undefined
  • [45] Shimada Y(undefined)undefined undefined undefined undefined-undefined
  • [46] Hiraoka A(undefined)undefined undefined undefined undefined-undefined
  • [47] Kumada T(undefined)undefined undefined undefined undefined-undefined
  • [48] Atsukawa M(undefined)undefined undefined undefined undefined-undefined
  • [49] Hirooka M(undefined)undefined undefined undefined undefined-undefined
  • [50] Tsuji K(undefined)undefined undefined undefined undefined-undefined